Publications

Li, Yang, Jake Maule, Jadee L. Neff, Chad M. McCall, Sarah Rapisardo, Anand S. Lagoo, Lian-He Yang, Regina D. Crawford, Yue Zhao, and Endi Wang. “Myeloid neoplasms in the setting of sickle cell disease: an intrinsic association with the underlying condition rather than a coincidence; report of 4 cases and review of the literature..” Mod Pathol 32, no. 12 (December 2019): 1712–26. https://doi.org/10.1038/s41379-019-0325-6.

PMID
31371806
Full Text

Yeo, Tsin W., Peggy A. Bush, Youwei Chen, Sarah P. Young, Haoyue Zhang, David S. Millington, Donald L. Granger, Esther D. Mwaikambo, Nicholas M. Anstey, and J Brice Weinberg. “Glycocalyx breakdown is increased in African children with cerebral and uncomplicated falciparum malaria..” Faseb J 33, no. 12 (December 2019): 14185–93. https://doi.org/10.1096/fj.201901048RR.

PMID
31658834
Full Text

Darbari, Isha, Emily Jacobs, Olivia Gordon, Diane Weiss, Kim Winship, James F. Casella, John J. Strouse, and Clifford M. Takemoto. “Correlates of successful transition in young adults with sickle cell disease..” Pediatr Blood Cancer 66, no. 12 (December 2019). https://doi.org/10.1002/pbc.27939.

PMID
31429531
Full Text

Gollomp, Kandace, Amrita Sarkar, Gowthami Arepally, Douglas B. Cines, M Anna Kowalska, Lubica Rauova, and Mortimer Poncz. “Understanding How Fc-Modification Transforms a Pathogenic Heparin-Induced Thrombocytopenia (HIT)-like Monoclonal Antibody into a Novel Treatment for Sepsis..” Blood 134, no. Supplement_1 (November 13, 2019). https://doi.org/10.1182/blood-2019-123132.

PMID
31723995
Full Text

Gollomp, Kandace, Amrita Sarkar, Sanjiv Harikumar, Steven H. Seeholzer, Gowthami Morey Arepally, Kristin Mara Hudock, Lubica Rauova, M Anna Kowalska, and Mortimer Poncz. “Understanding how Fc-modification transforms a pathogenic HIT-like monoclonal antibody into a novel treatment for sepsis..” Blood, November 13, 2019. https://doi.org/10.1182/blood.2019002329.

PMID
31722003
Full Text

Knoebl, Paul, Spero Cataland, Flora Peyvandi, Paul Coppo, Marie Scully, Johanna A. Kremer Hovinga, Ara Metjian, et al. “Efficacy and safety of open-label caplacizumab in patients with exacerbations of acquired thrombotic thrombocytopenic purpura in the HERCULES study..” J Thromb Haemost, November 5, 2019. https://doi.org/10.1111/jth.14679.

PMID
31691462
Full Text

Knoebl, Paul, Spero Cataland, Flora Peyvandi, Paul Coppo, Marie Scully, Johanna A. Kremer Hovinga, Ara Metjian, et al. “Efficacy and safety of open-label caplacizumab in patients with exacerbations of acquired thrombotic thrombocytopenic purpura in the HERCULES study..” J Thromb Haemost, November 5, 2019. https://doi.org/10.1111/jth.14679.

PMID
31691462
Full Text

Pishko, Allyson M., Daniel S. Lefler, Phyllis Gimotty, Koosha Paydary, Sara Fardin, Gowthami M. Arepally, Mark Crowther, et al. “The risk of major bleeding in patients with suspected heparin-induced thrombocytopenia..” J Thromb Haemost 17, no. 11 (November 2019): 1956–65. https://doi.org/10.1111/jth.14587.

PMID
31350937
Full Text

Yacoub, Abdulraheem, John Mascarenhas, Heidi Kosiorek, Josef T. Prchal, Dmitry Berenzon, Maria R. Baer, Ellen Ritchie, et al. “Pegylated interferon alfa-2a for polycythemia vera or essential thrombocythemia resistant or intolerant to hydroxyurea..” Blood 134, no. 18 (October 31, 2019): 1498–1509. https://doi.org/10.1182/blood.2019000428.

PMID
31515250
Full Text

Yeo, Tsin W., J Brice Weinberg, Daniel A. Lampah, Enny Kenangalem, Peggy Bush, Youwei Chen, Richard N. Price, et al. “Glycocalyx Breakdown Is Associated With Severe Disease and Fatal Outcome in Plasmodium falciparum Malaria..” Clin Infect Dis 69, no. 10 (October 30, 2019): 1712–20. https://doi.org/10.1093/cid/ciz038.

PMID
30753363
Full Text

Pages